nach oben

Angiogenesis

Erschienen in:

02.04.2020 | Letter

Angiostatic effects of ascorbic acid: current status and future perspectives

verfasst von: Muhammad Torequl Islam

Erschienen in: Angiogenesis | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Anti-angiogenesis effect of ascorbic acid (AA) is still controversial. However, most of the scientific evidence suggests that AA has anti-angiogenesis effects on a number of test systems, including laboratory animals, human beings, and their derived cell lines. The information provided in this paper suggests that AA may be a hopeful angiostatic agent for the treatment of cancer.

Shenoy N, Creagan E, Witzig T, Levine M (2018) Ascorbic acid in cancer treatment: let the phoenix fly. Cancer Cell 34(5):700–706. https://doi.org/10.1016/j.ccell.2018.07.014 CrossRefPubMedPubMedCentral

Schoenfeld JD, Sibenaller ZA, Mapuskar KA (2017) O₂^•– and H₂O₂-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell 31(4):487-500.e8. https://doi.org/10.1016/j.ccell.2017.02.018 CrossRefPubMedPubMedCentral

Ramjiawan RR, Griffioen AW, Duda DG (2017) Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy? Angiogenesis 20:185–204CrossRef

Padayatty SJ, Levine M. Vitamin C (2016) physiology: the known and the unknown and Goldilocks. Oral Dis 22:463–493CrossRef

Macan AM, Kraljević TG, Raić-Malić S (2019) Therapeutic perspective of vitamin C and its derivatives. Antioxidants (Basel) 8:247. https://doi.org/10.3390/antiox8080247 CrossRef

Pawlowska E, Szczepanska J, Blasiak J (2019) Pro- and antioxidant effects of vitamin C in cancer in correspondence to its dietary and pharmacological concentrations. Oxid Med Cell Longev 2019:7286737. https://doi.org/10.1155/2019/7286737 CrossRefPubMedPubMedCentral

Telang S, Clem AL, Eaton JW, Chesney J (2007) Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model. Neoplasia 9:47–56CrossRef

Mikirova NA, Ichim TE, Riordan NH (2008) Anti-angiogenic effect of high doses of ascorbic acid. J Transl Med 6:50. https://doi.org/10.1186/1479-5876-6-50 CrossRefPubMedPubMedCentral

Mikirova NA, Casciari JJ, Riordan NH (2010) Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo. J Angiogenes Res 2:2. https://doi.org/10.1186/2040-2384-2-2 CrossRefPubMedPubMedCentral

10.

Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M (2005) Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells. Oncol Rep 14:1399–1404PubMed

11.

Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M (2005) Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis. Oncol Rep 14:807–815PubMed

12.

Peyman GA, Kivilcim M, Morales AM, DellaCroce JT, Conway MD (2007) Inhibition of corneal angiogenesis by ascorbic acid in the rat model. Graefes Arch Clin Exp Ophthalmol 245:1461–1467CrossRef

13.

Mousa AS, Mousa SA (2005) Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53. Nutr Cancer 53:104–110CrossRef

14.

Ashino H, Shimamura M, Nakajima H et al (2003) Novel function of ascorbic acid as an angiostatic factor. Angiogenesis 6:259–269CrossRef

15.

Orosz KE, Gupta S, Hassink M, Abdel-Rahman M, Moldovan L, Davidorf FH, Moldovan NI (2004) Delivery of antiangiogenic and antioxidant drugs of ophthalmic interest through a nanoporous inorganic filter. Mol Vis 10:555–565PubMed

16.

Castro M, Caprile T, Astuya A et al (2001) High-affinity sodium-vitamin C co-transporters (SVCT) expression in embryonic mouse neurons. J Neurochem 78:815–823CrossRef

17.

Song YS, Kim SH, Sa JH, Jin C, Lim CJ, Park EH (2003) Anti-angiogenic, antioxidant and xanthine oxidase inhibition activities of the mushroom Phellinus linteus. J Ethnopharmacol 88:113–116CrossRef

18.

Yeom C-H, Lee G, Park J-H et al (2009) High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. J Transl Med 7:70. https://doi.org/10.1186/1479-5876-7-70 CrossRefPubMedPubMedCentral

19.

Duffy AM, Bouchier-Hayes DJ, Harmey JH. Vascular endothelial growth factor (vegf) and its role in non-endothelial cells: autocrine signalling by vegf. madame curie bioscience database. https://www.ncbi.nlm.nih.gov/books/NBK6482/

20.

Ulker E, Parker WH, Raj A, Qu Z-c, May JM (2016) Ascorbic acid prevents VEGF-induced increases in endothelial barrier permeability. Mol Cell Biochem 412:73–79CrossRef

21.

Sant DW, Camarena V, Mustafi S et al (2018) Ascorbate suppresses VEGF expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 59:3608–3618CrossRef

22.

Stephenson CM, Levin RD, Spector T, Lis CG (2013) Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol 72:139–146CrossRef

23.

Luchtel RA, Bhagat T, Pradhan K, Jacobs WR Jr, Levine M, Verma A, Shenoy N (2020) High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. Proc Natl Acad Sci USA 117(3):1666–1677. https://doi.org/10.1073/pnas.1908158117 CrossRefPubMed

24.

Magrì A, Germano G, Lorenzato A et al (2020) High-dose vitamin C enhances cancer immunotherapy. Sci Transl Med 12(532):eaay8707. https://doi.org/10.1126/scitranslmed.aay8707 CrossRefPubMed

25.

Castelo-Branco PV, Alves HJ, Pontes RL, Maciel-Silva VL, Pereira SRF (2019) Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity. Int J Parasitol Drugs Drug Resist 9:8–15CrossRef

26.

Fowler AA, Syed AA, Knowlson S et al (2014) Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 12:32. https://doi.org/10.1186/1479-5876-12-32 CrossRefPubMedPubMedCentral

27.

van Gorkom GNY, Lookermans EL, Van Elssen Catharina HMJ, Bos GMJ (2019) The effect of vitamin C (ascorbic acid) in the treatment of patients with cancer: a systematic review. Nutrients 11:977. https://doi.org/10.3390/nu11050977 CrossRefPubMedCentral

Titel: Angiostatic effects of ascorbic acid: current status and future perspectives
verfasst von: Muhammad Torequl Islam
Publikationsdatum: 02.04.2020
Verlag: Springer Netherlands
Erschienen in: Angiogenesis / Ausgabe 3/2020
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI: https://doi.org/10.1007/s10456-020-09719-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself

Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice

Raftlin is recruited by neuropilin-1 to the activated VEGFR2 complex to control proangiogenic signaling

Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia

Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis

d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3